Posts

Showing posts from June, 2025

Cancer Drugs Fast-Tracked by the FDA in May 2025

Image
In May 2025, the U.S. Food and Drug Administration (FDA) granted fast track designations to several key oncology drugs for cervical, blood, and lung cancers, among others. ISB 2001 for Relapsed/Refractory Multiple Myeloma On May 5,  Ichnos Glenmark Innovation announced  that the FDA granted fast track designation to ISB 2001, an investigational trispecific antibody, for the treatment of adults with relapsed or refractory  multiple myeloma  who have received at least three prior lines of therapy, including a proteasome inhibitor, an immunomodulatory agent, and an anti-CD38 monoclonal antibody. “Our trispecific candidate is designed to enhance tumor targeting while reducing on-target, off-tumor toxicity,” said Cyril Konto, MD, CEO and president of IGI, in a news release. ISB 2001 was well-tolerated with manageable toxicities and demonstrated robust antimyeloma activity in heavily pretreated patients, according to data presented at the  2025 American Society of Cli...

How AI is Revolutionizing Cancer Research and Patient Care in 2025

Image
Cancer care is undergoing a profound transformation in 2025, driven by the extraordinary capabilities of artificial intelligence (AI). From early detection to personalized treatment and drug development, AI is reshaping every facet of oncology, offering new hope for patients and clinicians alike. Precision Oncology: Tailoring Treatment Like Never Before One of the most groundbreaking impacts of AI is in precision oncology—the customization of cancer treatment based on the unique genetic and molecular profile of each patient’s tumor. AI algorithms can now analyze vast datasets that include genomic sequencing, gene expression, proteomics, clinical records, and imaging data simultaneously. This enables oncologists to identify specific mutations or biomarkers that predict how a tumor will respond to various therapies. For example, AI platforms help match patients with targeted therapies or immunotherapies most likely to be effective for their cancer subtype. Studies have shown AI recommend...

New Drug Blocks Key Enzyme to Slow Cancer Growth - Johns Hopkins University School of Medicine (2025)

Image
A 2025 study from Johns Hopkins suggests that blocking a key enzyme could help stop cancer cells from growing. The enzyme, called Pol 1, helps cells make ribosomal RNA, which is needed to build proteins. When researchers blocked Pol 1 using a drug, it triggered a stress response in cancer cells that slowed their growth. The study found this treatment worked especially well in cancers with certain genetic problems, like mismatch repair deficiency (MMRd), which is common in colorectal, stomach, and uterine cancers. In lab tests, a new drug called BOB-42 reduced tumor growth by up to 77% in some cases. Scientists also discovered that this approach could help the immune system spot cancer cells more easily. They believe combining Pol 1 blockers with immunotherapy may improve treatment results, giving hope to patients with cancers that don’t respond well to current options. "Ribosome biogenesis has long been known as a hallmark of cancer," says study leader Marikki Laiho, M.D., Ph...

Are CT Scans Increasing Your Cancer Risk? What You Need to Know

Image
Each year, millions of Americans undergo computed tomography (CT) scans without realizing the hidden risks tied to this common medical procedure. While CT imaging plays a large role in modern diagnostics, it also exposes you to a type of radiation that quietly damages your cells and builds up over time. Unlike everyday background exposure, the ionizing radiation from medical scans directly injures DNA, setting the stage for cancer years or even decades later. Few people are warned about how even a single scan adds to your lifetime cancer risk, or that safer alternatives often exist. What’s even less known is how early safety claims around medical radiation were shaped by corporate interests, not unbiased science. As you’ll soon see, historical evidence reveals a long-standing pattern of minimizing the true dangers to protect profits over patients. If you want to take smarter control of your health, it’s important to understand the real risks behind CT imaging, and how to protect your...